Table 3.
Treatment | Starter (1–10 d) | Grower (11–24 d) | Finisher (25–42 d) | Total (1–42 d) |
---|---|---|---|---|
NC1 | 20.16a | 59.53a | 66.68a | 53.22a |
PCAFB1 | 17.14b | 32.14d | 30.55f | 27.89f |
PCOTA1 | 17.31a,b | 27.23d | 28.22f | 25.29f |
PCAFB+200 BBR2 | 18.35a,b | 36.67c,d | 47.56c,d | 36.97d,e |
PCAFB+400 BBR2 | 18.00a,b | 50.11a,b | 47.72c,d | 41.44c,d |
PCAFB+600 BBR2 | 19.69a,b | 56.19a | 57.36b | 48.00b |
PCOTA+200 BBR2 | 17.37a,b | 37.87c,d | 39.42e | 33.65e |
PCOTA+400 BBR2 | 19.20a,b | 44.01b,c | 40.79d,e | 36.72d,e |
PCOTA+600 BBR2 | 19.03a,b | 51.16a,b | 59.14b,c | 43.93b,c |
P-Value | 0.0001 | 0.0001 | 0.0001 | 0.0050 |
SEM | 0.59 | 2.33 | 1.51 | 1.09 |
a–fSuperscripts within columns indicate significant differences between treatments (P < 0.05).
NC, negative control diet with no additives; PCAFB, NC + 2 ppm AFB (positive control AFB); PCOTA, NC + 2 ppm OTA (positive control OTA).
Berberine supplementation (mg/kg diet).